Don’t let COVID-19 stop patients from delaying important health screenings! Encourage them to use programs like our diabetic retinopathy screening pilot.
COVID-19 can be scary for patients but skipping important health screenings can be even scarier. This can be especially true for those with underlying health issues, like diabetes.
Between 40 and 45 percent of Americans diagnosed with diabetes have some stage of diabetic retinopathy, although only about half are aware of it.1 Help your patients with Type 1 Adult Diabetes or Type 2 Diabetes stay on top of their eye health by encouraging them to participate in the diabetic retinopathy screening pilot we have in place with Laboratory Corporation of America® Holdings (LabCorp) and Wills Eye Hospital.
The diabetic retinopathy screening pilot is currently available at three LabCorp Patient Service Centers in Northeast Philadelphia:
- 101 East Olney Avenue, Philadelphia, PA 19120 (267-335-4106)
- 15200 Bustleton Avenue, Philadelphia, PA 19116 (215-437-7970)
- 3790 Morrell Avenue, Philadelphia, PA 19114 (267-538-3598)
For more information about the pilot program, please visit the LabCorp
diabetic retinopathy website.
1National Eye Institute. Available from: